145 related articles for article (PubMed ID: 31595984)
21. Efficacy of glycogen synthase kinase-3β targeting against osteosarcoma via activation of β-catenin.
Shimozaki S; Yamamoto N; Domoto T; Nishida H; Hayashi K; Kimura H; Takeuchi A; Miwa S; Igarashi K; Kato T; Aoki Y; Higuchi T; Hirose M; Hoffman RM; Minamoto T; Tsuchiya H
Oncotarget; 2016 Nov; 7(47):77038-77051. PubMed ID: 27780915
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a.
Li C; Zhang S; Qiu T; Wang Y; Ricketts DM; Qi C
Cancer Biol Ther; 2019; 20(4):413-422. PubMed ID: 30489194
[TBL] [Abstract][Full Text] [Related]
23. Proline oxidase, a p53-induced gene, targets COX-2/PGE2 signaling to induce apoptosis and inhibit tumor growth in colorectal cancers.
Liu Y; Borchert GL; Surazynski A; Phang JM
Oncogene; 2008 Dec; 27(53):6729-37. PubMed ID: 18794809
[TBL] [Abstract][Full Text] [Related]
24. miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3β signaling pathway.
Wang Y; Zhao M; Liu J; Sun Z; Ni J; Liu H
Oncol Rep; 2017 Sep; 38(3):1715-1723. PubMed ID: 28713974
[TBL] [Abstract][Full Text] [Related]
25. P65-mediated miR-590 inhibition modulates the chemoresistance of osteosarcoma to doxorubicin through targeting wild-type p53-induced phosphatase 1.
Long X; Lin XJ
J Cell Biochem; 2019 Apr; 120(4):5652-5665. PubMed ID: 30387173
[TBL] [Abstract][Full Text] [Related]
26. PIK3CD induces cell growth and invasion by activating AKT/GSK-3β/β-catenin signaling in colorectal cancer.
Chen JS; Huang JQ; Luo B; Dong SH; Wang RC; Jiang ZK; Xie YK; Yi W; Wen GM; Zhong JF
Cancer Sci; 2019 Mar; 110(3):997-1011. PubMed ID: 30618098
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of hsa_circ_0007534 predicts unfavorable prognosis for osteosarcoma and regulates cell growth and apoptosis by affecting AKT/GSK-3β signaling pathway.
Li B; Li X
Biomed Pharmacother; 2018 Nov; 107():860-866. PubMed ID: 30142548
[TBL] [Abstract][Full Text] [Related]
28. A Tcf/Lef element within the enhancer region of the human NANOG gene plays a role in promoter activation.
Kim CG; Chung IY; Lim Y; Lee YH; Shin SY
Biochem Biophys Res Commun; 2011 Jul; 410(3):637-42. PubMed ID: 21689639
[TBL] [Abstract][Full Text] [Related]
29. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
[TBL] [Abstract][Full Text] [Related]
30. Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells.
Ghosh JC; Altieri DC
Clin Cancer Res; 2005 Jun; 11(12):4580-8. PubMed ID: 15958644
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-340-5p suppresses osteosarcoma development by down-regulating the Wnt/β-catenin signaling pathway via targeting the STAT3 gene.
Rongxin S; Pengfei L; Li S; Xiaochen J; Yihe H
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):982-991. PubMed ID: 30779064
[TBL] [Abstract][Full Text] [Related]
32. Subfunctionalization and neofunctionalization of vertebrate Lef/Tcf transcription factors.
Klingel S; Morath I; Strietz J; Menzel K; Holstein TW; Gradl D
Dev Biol; 2012 Aug; 368(1):44-53. PubMed ID: 22641013
[TBL] [Abstract][Full Text] [Related]
33. p53 protein regulates Hsp90 ATPase activity and thereby Wnt signaling by modulating Aha1 expression.
Okayama S; Kopelovich L; Balmus G; Weiss RS; Herbert BS; Dannenberg AJ; Subbaramaiah K
J Biol Chem; 2014 Mar; 289(10):6513-6525. PubMed ID: 24451373
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of miR-192 inhibits cell growth and invasion and induces cell apoptosis by targeting TCF7 in human osteosarcoma.
Wang Y; Zhang S; Xu Y; Zhang Y; Guan H; Li X; Li Y; Wang Y
Tumour Biol; 2016 Nov; 37(11):15211-15220. PubMed ID: 27683056
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-338-3p inhibits tumor growth and metastasis in osteosarcoma cells by targeting RUNX2/CDK4 and inhibition of MAPK pathway.
Jia F; Zhang Z; Zhang X
J Cell Biochem; 2019 Apr; 120(4):6420-6430. PubMed ID: 30484892
[TBL] [Abstract][Full Text] [Related]
36. The EWS/FLI1 oncogenic protein inhibits expression of the Wnt inhibitor DICKKOPF-1 gene and antagonizes beta-catenin/TCF-mediated transcription.
Navarro D; Agra N; Pestaña A; Alonso J; González-Sancho JM
Carcinogenesis; 2010 Mar; 31(3):394-401. PubMed ID: 20019092
[TBL] [Abstract][Full Text] [Related]
37. Suppression of gastric cancer cell growth by targeting the beta-catenin/T-cell factor pathway.
Dvory-Sobol H; Sagiv E; Liberman E; Kazanov D; Arber N
Cancer; 2007 Jan; 109(2):188-97. PubMed ID: 17149756
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-152 inhibits cell proliferation of osteosarcoma by directly targeting Wnt/β-catenin signaling pathway in a DKK1-dependent manner.
Zhao X; Sun S; Xu J; Luo Y; Xin Y; Wang Y
Oncol Rep; 2018 Aug; 40(2):767-774. PubMed ID: 29845282
[TBL] [Abstract][Full Text] [Related]
39. The anti-cancer activity of an andrographolide analogue functions through a GSK-3β-independent Wnt/β-catenin signaling pathway in colorectal cancer cells.
Reabroi S; Saeeng R; Boonmuen N; Kasemsuk T; Saengsawang W; Suksen K; Zhu W; Piyachaturawat P; Chairoungdua A
Sci Rep; 2018 May; 8(1):7924. PubMed ID: 29784906
[TBL] [Abstract][Full Text] [Related]
40. Polyphyllin I suppresses human osteosarcoma growth by inactivation of Wnt/β-catenin pathway in vitro and in vivo.
Chang J; Li Y; Wang X; Hu S; Wang H; Shi Q; Wang Y; Yang Y
Sci Rep; 2017 Aug; 7(1):7605. PubMed ID: 28790389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
